Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from BMO Capital Markets

Chefs' Warehouse Says Decade of Investments Is Fueling Sales Momentum

Chefs' Warehouse (NASDAQ:CHEF) executives said recent sales momentum reflects a combination of healthier customer demand and company-specific gains from years of investment in facilities, training, technology and category expansion. Speaking at a BMO Capital Markets event hosted by food retail anal

MarketBeat

Bayer Aktiengesellschaft Backs Crop Science Targets as Seed Pipeline Gains Momentum

Bayer Aktiengesellschaft (ETR:BAYN) executives said the company’s Crop Science division remains on track with a five-year plan centered on cost savings, margin expansion and a slate of product launches in seeds, traits and crop protection. Speaking at a BMO Capital Markets event, Rodrigo Santos, Pr

MarketBeat

AI In Finance: How Autonomous Agents Are Changing Fintech

Benzinga Head of Product Tommy Cotter recently hosted a discussion at our flagship event, Fintech Day Awards 2025, in New York. The panel, titled "AI In Finance: How Autonomous Agents are Changing Financial Services,” included participants who examined current use cases of agentic AI in fintech and the future of…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Apple, PG&E, D.R. Horton And An Industrial Stock On CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Brian Belski, chief investment strategist at BMO Capital Markets, named TopBuild Corp. (NYSE:BLD) as his final trade.

Benzinga

Analysts Love This Hidden-Gem Generative AI Stock

Analysts see MongoDB as an AI sleeper, with vector search tech and strong cash fueling growth.

Barchart

Chipotle Mexican Grill Q2 Sales Decline, June-July Boost Keeps Analysts Bullish

Shares of Chipotle Mexican Grill Inc (NYSE:CMG) tanked in early trading on Thursday, after the company reported a revenue miss for the second quarter.

Benzinga

3 Dividend Stocks to Buy Now for a Bulletproof Portfolio, According to Analysts.

According to BMO Capital Markets, investors can shield their portfolios from market volatility by investing in dividend stocks like Aflac, CSX, and Deere, which offer a combination of steady income and growth potential.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Stock Market Today: Stocks Tumble for Second Straight Session of 2024

Economic data and the minutes from the latest Fed meeting failed to light a bid under equities.

Kiplinger

Markets Today: U.S. Stocks See Support After Japan Maintains Negative Interest Rates

Morning Markets March E-Mini S&P 500 futures (ES H24) are up +0.17%, and March Nasdaq 100 E-Mini futures (NQH2 4) are up +0.11%. Stock index futures this morning are slightly higher on carryover support from a rally in Japanese stocks after the Bank of Japan (BOJ) maintained negative interest rates...

Barchart

4 Starbucks Analysts React To Investor Day: 'Attractive Risk-Reward And Valuation'

Starbucks Corporation (NASDAQ: SBUX) shares traded high by 1.2% on Wednesday after the company held its first investor day event since announcing Laxman Narasimhan will be taking over as the new CEO.

Benzinga

8 Netflix Analysts React To Q2 Earnings Beat, Subscriber Guidance, Ad-Supported Tier

Netflix, Inc. (NASDAQ: NFLX) shares gained 7.1% on Wednesday after the company reported better-than-expected subscriber losses in the second quarter and detailed plans to launch a new, low-cost, ad-supported subscription tier.

Benzinga

BMO Capital Sees Over 400% Upside For This Small Gene-Editing Stock

BMO Capital Markets initiated coverage on Graphite Bio Inc (NASDAQ:GRPH), with a price target of $12 and an Outperform rating. The analyst notes that Graphite's gene editing approach involves a DNA repair mechanism that is known to be less vulnerable to errors. BMO writes that Graphite's platform is expected to be safer than existing…

Benzinga

Legend Biotech Shares Move Higher After Bullish BMO Pitch

BMO Capital Markets initiated coverage on Legend Biotech Corporation (NASDAQ:LEGN) with a price target of $77, and an Outperform rating. The analyst says the company's recently approved Carvykti for multiple myeloma is best-in-class late-line CAR T therapy. Related: EMA's CHMP Clears Janssen, Legend's Multiple Myeloma CAR-T Therapy Though the analyst expects a gradual increase in sales due…

Benzinga

BMO Sees 'Differentiated Gene Editing Platform' For This Small-Cap Stock

BMO Capital Markets initiated the coverage on Precision BioSciences Inc (NASDAQ:DTIL) with an Outperform rating and a price target of $7. The analyst said the thesis is based on: The company's proprietary gene-editing platform, whose mechanism is differentiated in a CRISPR-dominated space, offers several advantages. A diversified pipeline. Asymmetric risk/reward skewed to the upside.…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

3 Reason Why This Analyst Says CRISPR Therapeutics Is A Biotech Winner

CRISPR Therapeutics AG (NASDAQ: CRSP) has a diversified pipeline with potential CTX001 commercialization and CTX110 potential approval expected in 2024, according to BMO Capital Markets.

Benzinga

9 Salesforce Analysts React To Q1 Earnings Beat: 'Next Quality Software GARP Stock'

Salesforce Inc (NYSE: CRM) shares jumped Wednesday morning after the company reported first-quarter earnings and raised its profit forecast.

Benzinga

4 Urban Outfitters Analysts React To Q1 Earnings Miss, Rising Costs, Growing Inventory

Urban Outfitters, Inc. (NYSE: URBN) shares traded higher by 11.6% on Wednesday, despite the company reporting disappointing first-quarter earnings numbers.

Benzinga

4 Nordstrom Analysts React To Mixed Q1 Earnings: 'We Remain Skeptical'

Nordstrom, Inc. (NYSE: JWN) shares traded higher by 11% on Wednesday after the company reported strong first-quarter sales numbers and raised its full-year guidance.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

4 Ross Analysts React To Q1 Earnings Miss, Guidance Cut, Execution Missteps

Shares of Ross Stores, Inc. (NASDAQ: ROST) dropped 23.9% on Friday after the company became the latest retail stock to disappoint the market with its first-quarter numbers.

Benzinga

5 Walmart Analysts React To Mixed Q1 Earnings: 'Particularly Attractive Buying Opportunity'

Walmart Inc (NYSE: WMT) shares were in the clearance aisle Wednesday after the company reported rising costs related to supply chain problems and inflation in the first quarter.

Benzinga

Why These Beyond Meat Analysts Are Barbecuing Price Targets After $100M Q1 Loss: 'Lower Likelihood Of Disruption'

Beyond Meat Inc (NASDAQ: BYND) shares traded higher Thursday before moving lower in the afternoon, and remain down 56.6% year-to-date after the company reported a larger-than-expected first-quarter net lo

Benzinga

7 Walt Disney Analysts React To Q2 Earnings Miss, Subscriber Beat, Ongoing Asia Weakness

Walt Disney Co (NYSE: DIS) shares traded lower by 3.7% on Thursday after the company reported first-quarter earnings and said ongoing COVID-19 disruptions are weighing on its Asia theme park business.

Benzinga

'Long Road Of Rebuilding Begins': PayPal Analysts React To Mixed Q1 Earnings Report

Shares of PayPal Holdings Inc (NASDAQ: PYPL) gained 11% on Thursday after the company reported a revenue beat but cut its 2022 guidance.

Benzinga

'Modestly Better': 4 IBM Analysts React To Impressive Earnings Report

IBM (NYSE: IBM) shares traded higher by 7.7% on Wednesday after the company reported a first-quarter earnings beat as it continues to restructure its company.

Benzinga

Iamgold Stock Slips After BMO Capital Downgrade, Price Target Reduction

Iamgold Corp (TSX:IMG) (NYSE:IAG) has been downgraded to Market Perform from Outperform, and the price target has been lowered to $2.75 (a downside of 19.5%) from $4 by BMO Capital Markets analyst Jackie Przybylowski. The downgrade is partly on valuation as the company's share prices have appreciated YTD, says the analyst. According to Przybylowski, a…

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.